Filing Flows › Cerenome (CNSY) › Who owns the stock
Who owns Cerenome (CNSY) stock
19 funds reported Cerenome (CNSY) shares in their latest 13F filings, worth $2.8M in all. The largest holder is Vanguard Capital Management LLC ($1.3M). Last quarter 18 funds added to their stakes and 1 cut them.
Largest holders (13F)
| Fund | Shares | Value | Change | Quarter |
|---|---|---|---|---|
| Vanguard Capital Management LLC | 304,745 | $1.3M | new | 2026-06-30 |
| BlackRock | 95,983 | $419K | new | 2026-06-30 |
| Geode Capital Management, LLC | 76,155 | $333K | new | 2026-06-30 |
| Vanguard Fiduciary Trust | 36,868 | $161K | new | 2026-06-30 |
| Ashton Thomas Private Wealth, LLC | 34,306 | $150K | new | 2026-06-30 |
| State Street | 30,853 | $135K | new | 2026-06-30 |
| Citadel Advisors LLC | 25,597 | $112K | new | 2026-06-30 |
| Northern Trust | 15,516 | $68K | new | 2026-06-30 |
| Virtu Financial LLC | 15,343 | $67K | new | 2026-06-30 |
| Wells Fargo | 6,156 | $27K | new | 2026-06-30 |
| Vanguard Global Advisers, LLC | 2,282 | $10K | new | 2026-06-30 |
| Osaic Holdings | 2,000 | $9K | new | 2026-06-30 |
| Tower Research Capital LLC | 1,955 | $9K | new | 2026-06-30 |
| UBS Group AG | 470 | $2K | new | 2026-06-30 |
| SBI Securities | 251 | $1K | decrease | 2026-06-30 |
Cerenome's latest quarter
Cerenome, Q2 2026: revenue $411K (-70% year over year), net loss $9.0M, operating cash flow −$7.1M. The chart follows the revenue to costs, profit and cash.
Questions
Who owns the most CNSY stock?
By the latest 13F filings: Vanguard Capital Management LLC ($1.3M); BlackRock ($419K); Geode Capital Management, LLC ($333K); Vanguard Fiduciary Trust ($161K); Ashton Thomas Private Wealth, LLC ($150K).
What is the short interest in CNSY?
782,146 shares were sold short at the 2026-10-15 settlement, 4.42% of the float.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.